 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$92.59 |
$93.00 |
$87.03 |
$87.25 |
484.70K | | 04/15/2024 |
$87.18 |
$87.83 |
$84.33 |
$85.18 |
506.40K | | 04/16/2024 |
$84.51 |
$88.08 |
$84.44 |
$86.09 |
410.70K | | 04/17/2024 |
$87.31 |
$89.69 |
$86.77 |
$88.38 |
728.30K | | 04/18/2024 |
$87.93 |
$91.76 |
$86.56 |
$88.90 |
734.90K |
|
|
| Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. Co. delivers its approved medicines, AYVAKIT®/AYVAKYT® (avapritinib) and GAVRETO® (pralsetinib), to patients in the U.S. and Europe, and it is globally developing multiple programs for systemic mastocytosis lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. Co. is developing a portfolio of investigational EGFR inhibitors such as BLU-945, BLU-701, BLU-525 and BLU-451, to address a range of common and uncommon epidermal growth factor receptor activating mutations, including exon 19 deletions, the L858R mutation and exon 20 insertions. | |
|
Blueprint Medicines (BPMC) has the following price history information. Looking back at BPMC historical stock prices for the last five trading days, on April 12, 2024, BPMC opened at $92.59, traded as high as $93.00 and as low as $87.03, and closed at $87.25. Trading volume was a total of 484.70K shares. On April 15, 2024, BPMC opened at $87.18, traded as high as $87.83 and as low as $84.33, and closed at $85.18. Trading volume was a total of 506.40K shares. On April 16, 2024, BPMC opened at $84.51, traded as high as $88.08 and as low as $84.44, and closed at $86.09. Trading volume was a total of 410.70K shares. On April 17, 2024, BPMC opened at $87.31, traded as high as $89.69 and as low as $86.77, and closed at $88.38. Trading volume was a total of 728.30K shares. On April 18, 2024, BPMC opened at $87.93, traded as high as $91.76 and as low as $86.56, and closed at $88.90. Trading volume was a total of 734.90K shares.
BPMC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Blueprint Medicines shares, starting with a $10,000 purchase of BPMC, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/10/2015 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$31.49 |
|
| End price/share: |
$88.90 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
182.31% |
|
| Average Annual Total Return: |
12.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$28,224.57 |
|
| Years: |
8.86 |
|
|
|
| Date |
Close |
| 04/12/2024 | $87.25 | | 04/15/2024 | $85.18 | | 04/16/2024 | $86.09 | | 04/17/2024 | $88.38 | | 04/18/2024 | $88.90 |
|
|
Free BPMC Email Alerts:
